Back to Avoro Capital Advisors LLC Avoro Capital Advisors LLC

SYRESYRE

Showing 2 of 6 quarters

Position history for Avoro Capital Advisors LLCAvoro Capital Advisors LLC's holdings in SPYRE THERAPEUTICS INC

No. Avoro Capital Advisors exited its SYRE (Spyre Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 598,600 shares worth $17.6M. Avoro Capital Advisors first reported SYRE in Q3 2023 and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$17.6M

Total Shares Change

-598,600

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$23.28
0
2024-Q3
Decreased
598,600
-67.5%
$17.6M0.3%$29.41
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used